Berger, Scott B.
GlaxoSmithKline (United States)
3 papers on CoChat
Most cited papers
- Verified
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Berger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology
Cell death mechanisms and regulationNF-κB Signaling Pathways
Cited by 374
- Verified
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis
Takahashi, N., Vereecke, L., Bertrand, M. J. M., Duprez, L., Berger, S. B., Divert, T., Gonçalves, A., Sze, M., Gilbert, B., Kourula, S., et al. (2014) · Nature
Cell death mechanisms and regulationNF-κB Signaling Pathways
Cited by 318
- Verified
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
Kaiser, W. J., Daley-Bauer, L. P., Thapa, R. J., Mandal, P., Berger, S. B., Huang, C., Sundararajan, A., Guo, H., Roback, L., Speck, S. H., et al. (2014) · Proceedings of the National Academy of Sciences
Cell death mechanisms and regulationImmune Response and Inflammation
Cited by 291
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free